Profile
| Role | Director |
|---|---|
| Notability | 20/100 |
Board memberships
- Moderna, Inc.
- Mallinckrodt plc
Updated Jul 16, 2026
Hussain Abbas has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $265K.
| Role | Director |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-04 | MRNA | Moderna, Inc. | S — Open-market sale | 5.7K | $46.63 | $265K |
| 2026-05-04 | MRNA | Moderna, Inc. | M — Option exercise | 16.2K | — | |
| 2025-10-02 | MRNA | Moderna, Inc. | M — Option exercise | 1.4K | — | |
| 2025-07-31 | NONE | Mallinckrodt plc | F — Tax withholding / forfeiture | 3.4K | — | |
| 2025-07-31 | NONE | Mallinckrodt plc | M — Option exercise | 12.0K | — |
Hussain Abbas is a corporate insider — currently tracked as Director of Moderna, Inc. (MRNA). InsiderAlpha tracks every SEC Form 4 filing in real time.
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($265K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Hussain Abbas profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.